![Stephen Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Parker
Président chez
BIODEXA PHARMACEUTICALS PLC
Fortune : 136 496 $ au 31/05/2026
Profil
Stephen Barry Parker is the founder of UK Stem Cell Foundation.
Current roles include Executive Chairman at Sareum Holdings Plc since 2024, Non-Executive Chairman at Biodexa Pharmaceuticals Plc since 2022, Non-Executive Chairman at Drishti Discoveries Ltd. since 2021, Director at Sareum Ltd., Director at Sp2 Consulting Ltd., Non-Executive Director at Eternans Ltd. since 2019, Director at Sp2 Asset Management Ltd. since 2018, and Partner at Celtic Pharma Management LP since 2005.
Former roles include Non-Executive Chairman at Argent BioPharma Ltd. from 2019 to 2023, Non-Executive Chairman at Physiomics Plc from 2004 to 2005, Chairman at Ah Animal Healthcare Ltd., Chairman at Liverpool Chirochem Ltd. from 2017 to 2018, Director at Xenova Group Plc, Independent Non-Executive Director at Silence Therapeutics Plc from 2013 to 2019, Director at Houlihan Lokey Advisory Ltd., Director at Celtic Pharma Development UK Plc, Director at Novacta Biosystems Ltd., Director at PBB Devices Ltd., Director at Xenova Ltd., Non-Executive Director at Gammadelta Therapeutics Ltd., Director at Albucasis Ltd. from 2013 to 2019, Director at Celtic Pharma GP Ltd., Principal at Apax Partners LLP, Principal at Celtic Pharma Holdings Advisors LLP, Consultant at PA Consulting Group Holdings Ltd., Principal at Warburg Group Plc, Chief Financial Officer at Oxford GlycoSciences Plc in 2002, Principal at Barings Plc, Partner at Beehive Capital LLP, and Head-Partner Network, Research & Development at Bedford Royalties Ltd. Education includes a doctorate from the University of Oxford, an undergraduate degree from the University of East Anglia, and an MBA from Bayes Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAREUM HOLDINGS PLC 0,29 % | 26/03/2025 | 405 045 ( 0,29 % ) | 136 496 $ | 31/05/2026 |
| 12/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Stephen Parker
| Sociétés | Poste | Début |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Président | 20/06/2022 |
| SAREUM HOLDINGS PLC | Président | 17/05/2016 |
Sp2 Consulting Ltd. | Directeur/Membre du Conseil | - |
Eternans Ltd. | Directeur/Membre du Conseil | 01/07/2019 |
Drishti Discoveries Ltd.
 Drishti Discoveries Ltd. BiotechnologyHealth Technology Develops gene therapy that provides transformative treatments through RNA-targeting genetic therapies | Président | 01/01/2021 |
Sareum Ltd.
 Sareum Ltd. Drugstore ChainsRetail Trade Provides drug discovery services | Directeur/Membre du Conseil | - |
Sp2 Asset Management Ltd. | Directeur/Membre du Conseil | 01/09/2018 |
Celtic Pharma Management LP
 Celtic Pharma Management LP Investment ManagersFinance Celtic Pharma invests in life sciences companies located in Bermuda. The firm targets companies operating in the fields of biotechnology, pharmaceuticals and biological drugs. It provides financing for later stage companies and also takes controlling interest. | Private Equity Investor | 01/04/2005 |
Anciens postes connus de Stephen Parker
| Sociétés | Poste | Fin |
|---|---|---|
| ARGENT BIOPHARMA LIMITED | Président | 01/12/2023 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Stephen Parker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
33
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 33 |
|---|---|
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Sareum Holdings Plc
 Sareum Holdings Plc MiscellaneousMiscellaneous Operates as a holding company, which engages in the discovery and development of drug candidates for the treatment of cancers & autoimmune diseases | Miscellaneous |
Apax Partners LLP
 Apax Partners LLP Investment ManagersFinance Operates as a private equity advisory firm | Finance |
Argent BioPharma Ltd.
 Argent BioPharma Ltd. Pharmaceuticals: OtherHealth Technology Develops phytomedicine products | Health Technology |
Celtic Pharma Holdings Advisors LLP
 Celtic Pharma Holdings Advisors LLP Investment ManagersFinance Alternative investment manager | Finance |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PA Consulting Group Ltd.
 PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Warburg Group Plc
 Warburg Group Plc Regional BanksFinance Provides investment banking services | Finance |
GCA Altium Ltd.
 GCA Altium Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Developes and manufactures novel products for the diagnosis and treatment of human disease | Health Technology |
Barings Plc
 Barings Plc Regional BanksFinance Parent company of a group engaged in merchant banking, investment and related services. | Finance |
Physiomics Plc
 Physiomics Plc Miscellaneous Commercial ServicesCommercial Services Provides computational systems biology services and develops cutting-edge mathematical models | Commercial Services |
University of East Anglia
 University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celtic Pharma Management LP
Celtic Pharma Management LP Investment ManagersFinance Celtic Pharma invests in life sciences companies located in Bermuda. The firm targets companies operating in the fields of biotechnology, pharmaceuticals and biological drugs. It provides financing for later stage companies and also takes controlling interest. | Finance |
Celtic Pharma Development UK Plc
 Celtic Pharma Development UK Plc Financial ConglomeratesFinance Provides financial management services | Finance |
Bayes Business School
 Bayes Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UK Stem Cell Foundation
 UK Stem Cell Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Novacta Biosystems Ltd.
 Novacta Biosystems Ltd. BiotechnologyHealth Technology Discovers and develops drugs for treatment of bacterial infections | Health Technology |
Beehive Capital LLP
 Beehive Capital LLP Investment ManagersFinance Beehive Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for growth stage capital requirements. | Finance |
PBB Devices Ltd.
 PBB Devices Ltd. Medical SpecialtiesHealth Technology Designs, develops, and supplies non-invasive biomedical health technology | Health Technology |
Sareum Ltd.
Sareum Ltd. Drugstore ChainsRetail Trade Provides drug discovery services | Retail Trade |
Celtic Pharma GP Ltd. | |
Xenova Ltd. | |
Ah Animal Healthcare Ltd.
 Ah Animal Healthcare Ltd. BiotechnologyHealth Technology Develops biosuperior protein therapeutics | Health Technology |
Bedford Royalties Ltd.
 Bedford Royalties Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Biodexa Pharmaceuticals Plc
 Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
Sp2 Consulting Ltd. | |
Liverpool Chirochem Ltd.
 Liverpool Chirochem Ltd. BiotechnologyHealth Technology Engages in development and application of chiral chemical space & molecule drug discovery | Health Technology |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer | Health Technology |
Eternans Ltd. | |
Drishti Discoveries Ltd.
Drishti Discoveries Ltd. BiotechnologyHealth Technology Develops gene therapy that provides transformative treatments through RNA-targeting genetic therapies | Health Technology |
Sp2 Asset Management Ltd. |
